Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

94
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
94
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

102
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
102
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

237
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
237
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

49
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethanol's Dual Role as a Mediator and Green Solvent in Photocatalytic Hydrogen Atom Transfer-Enabled Formal Ring-Closing Metathesis toward 2-Quinolinones.

The Journal of organic chemistry·2026
Same author

SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF-κB and SOAT2.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Effect of ignition timing on combustion characteristic of the elliptical rotary engine under different rotary speeds.

Scientific reports·2026
Same author

A study on the effects of combined DBT and STEPPS interventions for adolescents with non-suicidal self-injury: a randomized controlled trial.

Frontiers in public health·2026
Same author

Comparison of minimally invasive single-position left transthoracic and esophageal hiatal approach versus laparoscopic transesophageal hiatus approach for Siewert type II adenocarcinoma of the esophagogastric junction.

Surgical endoscopy·2026
Same author

Meta-analysis and systematic review: efficacy of probiotics in combination with standard therapies for rotavirus enteritis.

Annals of medicine and surgery (2012)·2026

Related Experiment Video

Updated: May 11, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.2K

Relationship between smoking status and ulcerative colitis: a meta-analysis based on a case-control study.

Yong Mi1, Yue Tan1, Yangyang Yu1

  • 1Clinical College of Traditional Chinese Medicine, Inner Mongolia Medical University, Hohhot, 010020, China.

Scientific Reports
|April 17, 2025
PubMed
Summary

Smoking appears to protect against developing ulcerative colitis (UC) and may improve outcomes for those with existing UC. This meta-analysis confirms smoking

Keywords:
Case–control studyMeta-analysisSmoking statusUlcerative colitis

More Related Videos

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

763
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

179

Related Experiment Videos

Last Updated: May 11, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.2K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

763
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

179

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • Existing research suggests a link between smoking, reduced ulcerative colitis (UC) risk, and better disease management.
  • The complex interplay between smoking habits and UC requires further investigation, particularly regarding incidence and treatment outcomes.

Purpose of the Study:

  • To conduct a meta-analysis of case-control studies to examine the association between smoking and ulcerative colitis (UC).
  • To clarify the relationship between smoking, UC incidence, and therapeutic outcomes.

Main Methods:

  • A systematic meta-analysis was performed on data from nine case-control studies.
  • Studies were identified through comprehensive searches of databases including PubMed, Embase, Scopus, Web of Science, and China Knowledge.
  • The analysis focused on comparing smoking status (current smoking, non-smoking, smoking cessation) and its association with UC.

Main Results:

  • Current smoking showed a significant protective effect against UC compared to smoking cessation (pooled OR: 0.26, 95% CI: 0.21-0.32).
  • Non-smoking also demonstrated a protective effect compared to smoking cessation (pooled OR: 1.84, 95% CI: 1.13-3.30).
  • Current smoking was significantly more protective than non-smoking (pooled OR: 0.48, 95% CI: 0.40-0.56), suggesting a dose-response or differential effect.

Conclusions:

  • Smoking appears to confer a protective effect against the onset of ulcerative colitis (UC).
  • Smoking may also play a role in reducing disease severity for individuals already diagnosed with UC.
  • Further research is warranted to understand the mechanisms behind these observed associations.